HDA to Host Traceability Seminar in August This Year
Annual industry seminar will help address compliance obstacles, as the DSCSA deadline approaches.
The Healthcare Distribution Alliance (HDA) will host its annual Traceability Seminar two months early, from Aug. 29–31, in Washington, D.C. The earlier date, the organization says, reflects the urgency surrounding the upcoming Drug Supply Chain Security Act (DSCSA) implementation deadline and the need to share information and solutions.
HDA has hosted the Traceability Seminar for 10 years. In 2023, the event is expected to bring together healthcare supply chain leaders, FDA, and other stakeholders to hold conversations as the industry learns more about the legislation’s implementation. DSCSA has impacted the way pharma products and their associated data move through the supply chain while increasing safety and security for patients—after its final deadline of Nov. 27, supply chain trading partners will be required to provide transaction data along with serialized product upon a change of ownership.
“With the pharmaceutical supply chain in a critical work period, the Traceability Seminar will provide an opportunity for industry stakeholders to share their experiences and challenges and, ultimately, align on outstanding compliance issues,” says Perry Fri, EVP, industry relations, membership and education, HDA. “In our role as a convener on all things DSCSA, HDA looks forward to hosting educational offerings to help supply chain partners forge ahead as the November deadline comes into view.”
